Novel oxazolone and pyrrolidinone-substituted arylamides

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 233/32 (2006.01) A61K 31/402 (2006.01) A61K 31/4166 (2006.01) A61K 31/421 (2006.01) A61K 31/423 (2006.01) A61K 31/497 (2006.01) A61K 31/501 (2006.01) A61K 31/506 (2006.01) C07D 207/27 (2006.01) C07D 263/20 (2006.01) C07D 401/14 (2006.01) C07D 413/10 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 473/00 (2006.01)

Patent

CA 2754654

Compounds of the formula I: or a pharmaceutically acceptable salt thereof, wherein, X, Y, R1, R2, R3, R4, R5, R6 and R7 are as defined herein. Also disclosed are methods of using the compounds for treating diseases associated with P2X3 and/or a P2X2/3 receptor antagonists and methods of making the compounds.

L'invention porte sur des composés représentés par la formule I : ou un sel pharmaceutiquement acceptable de ceux-ci, dans laquelle formule X, Y, R1, R2, R3, R4, R5, R6 et R7 sont tels que définis dans la description. L'invention porte également sur des procédés d'utilisation des composés pour le traitement de maladies associées à P2X3 et/ou comme antagonistes des récepteurs P2X2/3 et sur des procédés de fabrication des composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel oxazolone and pyrrolidinone-substituted arylamides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel oxazolone and pyrrolidinone-substituted arylamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel oxazolone and pyrrolidinone-substituted arylamides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1696842

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.